Anesthesia management of covid-19 associated ROC mucormycosis
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/01/039622
- Lead Sponsor
- Ashwini Yadavrao Sontakke
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
All patients posted for emergency or elective surgical resection of rhiniorbitocerebral mucormycosis under general anaesthesia
Exclusion Criteria
Lack of patients consent
coagulopathy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Study the outcome of patients in following parameters <br/ ><br>Requirement of inotropic support, ventilator support, ICU stay, total duration of hospitalization, co-morbid condition affecting the outcome <br/ ><br>2.Mortality rate and average mortality timeTimepoint: 1.Before Surgery <br/ ><br>2.Intraoperative <br/ ><br>3.Immediate postoperative <br/ ><br>4.Till discharge / Death <br/ ><br>5.30 days <br/ ><br>
- Secondary Outcome Measures
Name Time Method Early debidement of disease and outcome of patients. <br/ ><br>5.co-relation between predisposing factors and outcome of patients <br/ ><br>Timepoint: till dischage